SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Millennium Pharmaceuticals, Inc. (MLNM)
An SI Board Since February 1997
Posts SubjectMarks Bans Symbol
3044 135 0 MLNM
Emcee:  icanpickem Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1569GS on Mlnm: Stock rating: In-Line Coverage view: Neutral Mid-Cap Growth Price: Umopgcw-5/23/2003
1568Regarding my post 1501 and the Yahoo handle Boronate. <i> [The followingIcebrg-5/23/2003
1567anyone know anything about JPM? all new coverage today. Vertex Pharm VRTX JMP Sbob zagorin-5/22/2003
1566>> Antegren poses little competitive threat to remicade. Neither does mln0Icebrg-5/22/2003
1565<<<And they should of course wait and see what happens with Elan's rkrw-5/21/2003
1564They met the endpoint in one indication (UC) but missed the other (Crohn's).Icebrg-5/21/2003
1563Millennium Pharma Climbs on Drug Trial Results By TSC Staff 05/21/2003 05:41 PMSemiBull-5/21/2003
15624:44PM Millennium Pharm announces favorable phase II trial of investigational drSemiBull-5/21/2003
1561Help! they didnt meet the endpoint. as far as i can tell they dont say by how muMadharry-5/21/2003
1560Press Release Source: Millennium Pharmaceuticals, Inc. In Phase II Study, MilleIRWIN JAMES FRANKEL-5/21/2003
1559XOMA Announces Revision of Financing Agreement for Vascular Inflammation ProductIcebrg-5/21/2003
1558Millennium Ships VELCADE(TM) (bortezomib) for Injection Within Six Days of FDA ASemiBull-5/20/2003
1557A stock picker for the long haul Emster likes Alkermes, Ligand, Millenium BSemiBull-5/20/2003
1556Velcade in Relapsing-Refractory Multiple Myeloma: A Newsmaker Interview With PauIan@SI-5/20/2003
1555Velcade shipped. (eom)scaram(o)uche-5/20/2003
1554Is this a record or what? DNA's PR release added more than $8Billion to its Madharry-5/19/2003
1553S&P's 5/17/03: Velcade ... we believe peak annual sales of $500M ...IRWIN JAMES FRANKEL-5/19/2003
1552>>Lung Cancer Integration of the proteasome inhibitor PS-341 (Velcade) imicrocapfun-5/19/2003
1551Miljenko >>He is suddenly conservative.>> Perhaps because they areIcebrg-5/19/2003
1550He is suddenly conservative. Maybe it is best approach to be conservative and liMiljenko Zuanic-5/19/2003
1549New cancer drug wins FDA approval By William J. Cromie Gazette Staff When he IRWIN JAMES FRANKEL-5/18/2003
1548Saw this last week: >>06:10 ET ARIA Ariad Pharm surges on favorable courtmicrocapfun-5/18/2003
1547>> If however MLNM think it is worthwhile to mention a future conference pscaram(o)uche-5/17/2003
1546<i>Are Europeans thinking three times slower, than Americans?</i> Inigel bates-5/16/2003
1545Thanks SS. <<(xxiii) european approval update? - - typically lasts a yearMiljenko Zuanic-5/15/2003
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News